Adaptimmune’s Post

Scaling up cell therapy production can be a challenge. Traditional bioreactors struggle to meet the growing demands of the field. This video explores how G-Rex from Wilson Wolf Manufacturing, LLC addresses this critical issue: - Why flasks and bags limit scalability - The linear scaling capabilities of G-Rex - How G-Rex can future-proof your cell therapy manufacturing Watch the full video and discover how G-Rex can help you achieve your cell therapy goals: https://lnkd.in/evXtKYFF #celltherapy #scalability #G-Rex #ScaleReady

What’s the future of cell therapy? Get a glimpse through our recent collaboration with Georgia Tech. In this new study, researchers use our FINIA Fill and Finish System to help automate and streamline cell therapy product manufacturing. Read the paper to learn about advanced cryopreservation techniques and quality control measures. The protocol shares case studies based on real-world examples, implications for cell therapies, and good laboratory practices (GLPs) for cell manufacturing. Check out the study now: https://bit.ly/48HUfxN #celltherapy #genetherapy #cellandgenetherapy #innovation #labquality #biomanufacturing

Optimizing and containing costs for autologous cell therapies takes a lot of hard work and resources. Let us equip you with the insights and knowledge to make it happen. Download our infographic to get the full picture. https://lnkd.in/eD9BgwuR #autologouscelltherapy #celltherapy #cellandgenetherapy #celltherapymanufacturing

Optimizing and containing costs for autologous cell therapies takes a lot of hard work and resources. Let us equip you with the insights and knowledge to make it happen. Download our infographic to get the full picture. https://lnkd.in/eD9BgwuR #autologouscelltherapy #celltherapy #cellandgenetherapy #celltherapymanufacturing

Autologous Cell Therapy CoGs by process step (~$270k/dose) Besides labour, transduction/viral vector cost is the biggest component...

Think outside the capsid. Watch this webinar from Patrick Paez, Ph.D. of Aldevron on non-viral cell therapy manufacturing: #DanaherLifeSciences #DrugDiscovery #DrugDevelopment #celltherapy #manufacturing #Aldevron

ICYMI Novel, non-viral #CRISPR methods, with enrichment and selection systems, are showing promise in improving manufacturing costs, yields, and timelines. Learn more about these methods in our latest post and webinar, Going Non-Viral: How Cell Therapy Manufacturing is Moving Away From Viral Vectors https://lnkd.in/gwH6DDkT

Optimizing and containing costs for autologous cell therapies takes a lot of hard work and resources. Let us equip you with the insights and knowledge to make it happen. Download our infographic to get the full picture. https://lnkd.in/eD9BgwuR #autologouscelltherapy #celltherapy #cellandgenetherapy #celltherapymanufacturing

Novel, non-viral #CRISPR methods, with enrichment and selection systems, are showing promise in improving manufacturing costs, yields, and timelines. Learn more about these methods in our latest post and webinar, Going Non-Viral: How Cell Therapy Manufacturing is Moving Away From Viral Vectors https://lnkd.in/gi-RBiTQ

Sadik Kassim shares what motivates him to do the work that has advanced cell therapy development to a point that seemed impossible only a decade ago. Watch the series finale of 'Pioneers and visionaries of cell therapy': https://lnkd.in/dAfwxuGf #celltherapy #cellandgenetherapy #genomicmedicine #CART